In 2022, the highest death rate from influenza and pneumonia in Canada per 100,000 population was reported among those aged 90 years and older, with around 588 deaths. Individuals between 85 and 89 years followed, with a mortality rate from influenza and pneumonia of almost 210 deaths per 100,000 people. This statistic displays the death rate from influenza and pneumonia per 100,000 population in Canada during 2022, by age.

Mortality from pneumonia (ICD-10 J12-J18 equivalent to ICD-9 480-486). To reduce deaths from pneumonia. Legacy unique identifier: P00597

This statistic shows the deaths with pneumonia as an underlying cause in England and Wales in 2023, by age and gender. In this year, pneumonia was the underlying cause of over 4.6 thousand deaths for women aged 90 years and older.

This statistic shows the number of deaths from pneumonia in Taiwan in 2023, by age group. That year, 13 infants younger than one year died from pneumonia in Taiwan, whereas eight children between one and 14 years old were victims of pneumonia. The largest share of patients who died from the disease were senior citizens aged 65 and above.

In 2020, approximately 40 men and 29 women per 100,000 population died as a result of pneumonia in England and Wales. In every year in the provided time interval the mortality rate was higher among men, although both genders have experienced a general decline in deaths from pneumonia. Regionally, the North West had the highest mortality rate for both genders.

Pneumonia risk groups

The age groups most at risk from pneumonia is undoubtedly the older age groups. In 2021, in England and Wales, pneumonia was the cause of death for approximately 6.2 thousand over 90 year olds, of which 3.6 thousand were women. Furthermore, around 3.5 thousand individuals aged between 80 and 89 years lost their lives due to pneumonia in 2021.

Prevalence of other lung diseases

In England and Wales in 2019, the mortality rate from bronchitis for men was around 57 per 100,000 population, while the rate for women was approximately 44. The mortality rate for bronchitis was higher than pneumonia, this is caused in part by the large decline in the mortality rate of pneumonia since the year 2000.

Statistical information on confirmed cases and deaths of severe special infectious pneumonia starting in 2020, with secondary statistical tables stratified by region, age group, and gender. This data set is updated once a day according to the system's fixed schedule. At present, there are more cases of severe special infectious pneumonia imported from overseas than those confirmed by tests at airports or centralized quarantine stations and immediately isolated and treated, so their county and city information is not marked.

In 2022, a total of 5,985 people died from influenza and pneumonia in Canada. With 2,068 deaths reported during that year, individuals aged 90 years and older were the most affected age group by these diseases. This statistic shows the number of deaths from influenza and pneumonia in Canada in 2022, by age.

Death rate of a population adjusted to a standard age distribution. As most causes of death vary significantly with people's age and sex, the use of standardised death rates improves comparability over time and between countries, as they aim at measuring death rates independently of different age structures of populations. The standardised death rates used here are calculated on the basis of a standard European population (defined by the World Health Organization). Detailed data for 65 causes of death are available in the database (under the heading 'Data').

Influenza and pneumonia caused around 12.3 deaths in the U.S. per 100,000 population in 2019. Influenza and pneumonia are among the leading causes of death in the United States, accounting for around 1.6 percent of all deaths in 2020. Influenza, or the flu, is a viral infection that is highly contagious and especially common in the winter season. Influenza is a common cause of pneumonia, although most cases of the flu do not develop into pneumonia. Pneumonia is an infection or inflammation of the lungs and is particularly deadly among young children and the elderly.

Influenza cases

Influenza is very common in the United States, with an estimated 35 million cases reported in 2019-2020. Common symptoms of the flu include cough, fever, runny or stuffy nose, sore throat and headache. Symptoms can be mild but can also be severe enough to require medical attention. In 2019-2020, there were around 16 million influenza-related medical visits in the United States.

Prevention

To prevent contracting the flu people can take everyday precautions such as regularly washing their hands and avoiding those who are sick, but the best way to prevent the flu is by receiving the flu vaccination every year. Receiving a flu vaccination is especially important for young children and the elderly as they are most susceptible to flu complications and associated death. In 2021, around 75 percent of those aged 65 years and older received a flu vaccine, while only 38 percent of those aged 18 to 49 years had done so.

Age-stratified incidence (per 100,000 persons per year) and case-fatality rate of invasive pneumococcal disease (IPD), pneumococcal pneumonia (PP) and community-acquired pneumonia (CAP).

Effective September 27, 2023, this dataset will no longer be updated. Similar data are accessible from wonder.cdc.gov.

Deaths involving COVID-19, pneumonia, and influenza reported to NCHS by sex, age group, and jurisdiction of occurrence.

TABLE III. Deaths in 122 U.S. cities – 2016. 122 Cities Mortality Reporting System — Each week, the vital statistics offices of 122 cities across the United States report the total number of death certificates processed and the number of those for which pneumonia or influenza was listed as the underlying or contributing cause of death by age group (Under 28 days, 28 days –1 year, 1-14 years, 15-24 years, 25-44 years, 45-64 years, 65-74 years, 75-84 years, and ≥ 85 years). FOOTNOTE: U: Unavailable. —: No reported cases. * Mortality data in this table are voluntarily reported from 122 cities in the United States, most of which have populations of 100,000 or more. A death is reported by the place of its occurrence and by the week that the death certificate was filed. Fetal deaths are not included. † Pneumonia and influenza. § Total includes unknown ages.

Users can search this database pertaining to respiratory conditions such as asthma, pneumonia, bronchitis, and tuberculosis. BackgroundThe National Occupational Respiratory Mortality System (NORMS) is developed and maintained by National Institute of Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC). This surveillance system includes respiratory conditions such as: asthma, pneumonia, bronchitis, tuberculosis, lung cancer, and silicosis, among others. User FunctionalityUsers can generate national- or occupation-specific queries. Users can gener ate tables, charts and maps containing the summary statistics such as number of deaths, crude death rates, age-adjusted death rates, and years of potential life lost (YPLL ). Users can also download the dataset and/or data queries into Microsoft Excel. Data NotesThis website provides data history regarding revisions to the dataset. Data from additional sources (i.e., population estimates, comparative standard population, and life-table values) are also available. National mortality data is derived from the National Center for Health Statistics (NCHS) multiple cause of death records. These data are updated annually since 1968, unless otherwise indicated. Data are available on national, state, and county levels. The most recent d ata available is from 2007.

OBJECTIVE: To determine the incidence rate and mortality of community-acquired pneumonia (CAP) in adults in three cities in Latin America during a three-year period. DESIGN: Prospective population based study. SETTING: Healthcare facilities (outpatient centers and hospitals) in the cities of General Roca (Argentina), Rivera (Uruguay) and Concepcion (Paraguay). PARTICIPANTS: 2302 adults aged 18 years and older with CAP were prospectively enrolled between January 2012 and March 2015. MAIN OUTCOME MEASURES: Incidence rate of CAP in adults, predisposing conditions for disease, mortality at 14 days and at one year were estimated. Incidence rate of CAP, within each age group, was calculated by dividing the number of cases by the person-years of disease-free exposure time based on the last census; incidence rates were expressed per 1000 person-years. RESULTS: Median age of participants was 66 years, 46.44 % were men, 68% were hospitalized. Annual incidence rate was 7.03 (CI95% 6.64-7.44) per 1000 person-years in General Roca, 6.33 (CI95% 5.92-6.78) per 1000 person-years in Rivera and 1.76 (CI95% 1.55-2.00) per 1000 person-years in Concepcion. Incidence rates were highest in participants aged over 65 years. 82.4% had at least one predisposing condition and 48% had 2 or more (multi-morbidity). Chronic heart disease (43.6%) and smoking (37.3%) were the most common risk factors. 14-day mortality rate was 12.1% and one-year mortality was 24.9%. Multi-morbidity was associated with an increased risk of death at 14 days (OR 2.91; 2.23 to 3.80) and at 1 year (OR 3.00; 2.44 to 3.70). CONCLUSIONS: We found a high incidence rate of CAP in adults, ranging from 1.76 to 7.03 per 1000 person-years, in three cities in South America, disclosing the high burden of disease in the region. Efforts to improve prevention strategies are needed.

Years of life lost due to mortality from pneumonia (ICD-10 J12-J18). Years of life lost (YLL) is a measure of premature mortality. Its primary purpose is to compare the relative importance of different causes of premature death within a particular population and it can therefore be used by health planners to define priorities for the prevention of such deaths. It can also be used to compare the premature mortality experience of different populations for a particular cause of death. The concept of years of life lost is to estimate the length of time a person would have lived had they not died prematurely. By inherently including the age at which the death occurs, rather than just the fact of its occurrence, the calculation is an attempt to better quantify the burden, or impact, on society from the specified cause of mortality. Legacy unique identifier: P00519

Over 12 million people in the United States died from all causes between the beginning of January 2020 and August 21, 2023. Over 1.1 million of those deaths were with confirmed or presumed COVID-19.

Vaccine rollout in the United States Finding a safe and effective COVID-19 vaccine was an urgent health priority since the very start of the pandemic. In the United States, the first two vaccines were authorized and recommended for use in December 2020. One has been developed by Massachusetts-based biotech company Moderna, and the number of Moderna COVID-19 vaccines administered in the U.S. was over 250 million. Moderna has also said that its vaccine is effective against the coronavirus variants first identified in the UK and South Africa.

In 2019, an estimated 136,781 cases of pneumonia were recorded in Mexico. The country's oldest population had the highest amount of cases, with over 35,450 (or about 26 percent) of them occurring in adults aged 65 and older. Young people between the ages 11 and 19 had the least amount of pneumonia cases, with only about two percent (or 2,520) of the total 2019 cases. In 2018, more than 28 thousand people in Mexico died due to pneumonia and influenza, making these illnesses the seventh most common cause of death that year in the North American country.

Number of deaths and age-specific mortality rates for selected grouped causes, by age group and sex, 2000 to most recent year.

Legacy unique identifier: P00168